Retatrutide RT30 30mg*10vials

Retatroptide RT30 30mg x 10 Vials

Product Overview

Retatroptide RT30 is the flagship high-dose version in the entire retatroptide tri-target receptor agonist peptide series. As the most potent and highest-concentration GLP-1 and GIP and GCGR tri-target metabolic research peptide currently available, RT30 utilizes comprehensively upgraded superaffinity molecular optimization technology, supporting surpassing RT10, RT15, and RT20 in receptor binding efficiency, bioactivity intensity, and metabolic regulatory amplitude research. RT30 is specifically designed for top-tier preclinical mechanism studies, ultra-high dose gradient experiments, extreme metabolic model construction, and high-standard efficacy validation, serving as the preferred raw material for advanced metabolic pharmacology research.

Core Research Functions

Superior Synergistic Metabolic Regulation Through Three Pathways: Supports superior synergistic metabolic regulation through three pathways research.

Highly Activated GLP-1 and GIP Dual Pathways and Insulin Sensitivity Effective Improvement: Supports highly activated GLP-1 and GIP dual pathways research, insulin sensitivity effective improvement studies, glucose metabolism disorders related correction research, blood glucose homeostasis stabilization research, and potent long-lasting appetite suppression and satiety maintenance effects production research, thereby supporting in-depth research on glucose and lipid metabolism and insulin resistance in diabetes.

Significantly Enhanced GCGR Pathway and Resting Energy Expenditure Maximization: Supports significantly enhanced GCGR pathway research, resting energy expenditure maximization studies, visceral fat breakdown and systemic lipid oxidation significant acceleration research, severe dyslipidemia effective improvement research, and white adipose tissue remodeling promotion research.

Highly Significant Experimental Phenotypes and High-Precision High-Reliability Raw Data: Supports highly significant experimental phenotypes generation research and high-precision high-reliability raw data provision studies for challenging studies including severe refractory obesity, long-term metabolic remodeling, metabolic liver injury, and extreme dose-response correlations.

Retatroptide RT30 supports superior synergistic metabolic regulation through three pathways research. The highly activated GLP-1 and GIP dual pathways support insulin sensitivity effective improvement research, glucose metabolism disorders related correction research, blood glucose homeostasis stabilization research, and potent long-lasting appetite suppression and satiety maintenance effects production research, thereby supporting in-depth research on glucose and lipid metabolism and insulin resistance in diabetes. The significantly enhanced GCGR pathway supports resting energy expenditure maximization studies, visceral fat breakdown and systemic lipid oxidation significant acceleration research, severe dyslipidemia effective improvement research, and white adipose tissue remodeling promotion research. RT30 supports highly significant experimental phenotypes generation research and high-precision high-reliability raw data provision studies for challenging studies including severe refractory obesity, long-term metabolic remodeling, metabolic liver injury, and extreme dose-response correlations.

Core Product Advantages

Flagship-Level Ultimate Activity: RT30 is the top-tier iteration in the Retatrutide series, featuring a comprehensively upgraded molecular structure and extremely high target affinity. Its comprehensive metabolic regulatory capabilities support RT10, RT15, and RT20 far surpass research, delivering more significant experimental differences and meeting stringent standards of advanced scientific research.

Ultra-High 30mg Single-Vial Concentration: The highest commercial specification in the RT series, with a concentration three times that of the traditional 10mg product and 50 percent higher than the 20mg version. Suitable for long-term large animal models, ultra-high dose gradient controlled trials, and large-scale repetitive sample experiments, supporting frequent dilution and reagent changes caused errors minimization related research.

Extremely High Stability and Long-Lasting Effect: Advanced anti-degradation molecular modification technology supports in vitro and in vivo metabolic attenuation resistance research, maintaining high bioactivity throughout long-term experimental periods with minimal attenuation research, obtaining stable reproducible data research.

Pharmaceutical-Grade High Purity: Utilizing aseptic vacuum freeze-drying technology to support peptide activity full retention research. Each batch undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis COA quality certification, supporting ultra-low impurity content and low contamination risk research.

Standardized Bulk Packaging: 10 vials per box, integrated packaging, suitable for long-term laboratory storage, core preclinical drug research, key university research projects, and large-volume wholesale purchases.

Specifications and Quality Control

Format: Lyophilized powder, 30mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.